Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis

Molecular Metabolism(2020)10.1016/j.molmet.2020.101015Source: DataRank Database

The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis is a research paper published in Molecular Metabolism (2020). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

gen uniprot pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (46 grants)Impact (FWCI 5.12)OA: goldTopics (38)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (31)

Elizabeth Haythorne ORCID,Alejandra Tomás ORCID,Leena Haataja ORCID,Andreas Müller ORCID,Peter Arvan ORCID

Live enrichment

PubMed:32416313 PMC:PMC7322359 OpenAlex:https://openalex.org/W3026026716

National Institutes of Health

Grant: 12/0004431

National Institutes of Health

Grant: 16/0005485

National Institutes of Health

Grant: 17/0005681

National Institutes of Health

Grant: R01 DK48280

Innovative Medicines Initiative

Grant: 115881

Cancer Research UK

Grant: 104931/Z/14/Z

Diabetes UK

Grant: BDA 16/0005485

Diabetes UK

Grant: BDA/11/0004210

Diabetes UK

Grant: BDA/15/0005275

Medical Research Council

Grant: MR/J0003042/1

Medical Research Council

Grant: MR/L020149/1

Medical Research Council

Grant: MR/L02036X/1

Medical Research Council

Grant: MR/N00275X/1

Medical Research Council

Grant: MR/R022259/1

Biotechnology and Biological Sciences Research Council

Grant: 202902/Z/16/Z

Biotechnology and Biological Sciences Research Council

Grant: BB/L015129/1

Wellcome Trust

Grant: 212625/Z/18/Z

Wellcome Trust

Grant: WT098424AIA

European Federation of Pharmaceutical Industries and Associations

Grant: MR/R010676/1

Horizon 2020

Grant: 715884

Diabetes UK

Grant: 15/0005317

Biotechnology and Biological Sciences Research Council

Grant: BB/J015873/1

Medical Research Council

Grant: MR/K001981/1

Medical Research Council

Grant: MR/N009258/1

Wellcome Trust

Grant: 201325/Z/16/Z

Medical Research Council

Grant: MR/M012646/1

National Institute for Health Research (NIHR)

Grant: ACF-2010-21-012

National Institute for Health Research (NIHR)

Grant: CL-2017-21-002

Medical Research Council

Grant: MR/K023667/1

Medical Research Council

Grant: MR/S025618/1

NIDDK NIH HHS

Grant: R01 DK048280

Medical Research Council

Grant: 1854365

Medical Research Council

Grant: MR/N020472/1

Medical Research Council

Grant: MR/T002107/1

Academy of Medical Sciences

Grant: SGL019\1078

NIDDK NIH HHS

Grant: P30 DK020572

Bundesministerium fÃ¼r Bildung und Frauen

Bundesministerium für Bildung und Forschung

Horizon 2020 Framework Programme

Agency for Science, Technology and Research

Royal Society

Cancer Research UK

National University of Singapore

Servier

European Research Council

Institute of Molecular and Cell Biology

FWCI

5.12

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.molmet.2020.101015

publisherhttps://doi.org/10.1016/j.molmet.2020.101015

publisherhttps://api.elsevier.com/content/article/PII:S2212877820300892?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2212877820300892?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32416313

Fields of Study

Pancreatic function and diabetesDiabetes and associated disordersCaveolin-1 and cellular processes

MeSH Terms

Insulin SecretionAllelesAnimalsCarrier ProteinsDiabetes Mellitus, Type 2Disease Models, AnimalFemaleInsulinLipidsMaleMice, Inbred C57BLPhosphatidylinositolsPhosphoproteinsProtein BindingRisk FactorsMice, KnockoutSecretory VesiclesProteomicsLipid MetabolismInsulin-Secreting CellsMiceMolecular Docking Simulation

Keywords

BiologyProinsulinCell biologyInsulinPhosphatidylinositolInternal medicinePhosphorylationEndocrinologyPhosphoinositidesType 2 diabetesPancreatic Β-cellInsulin Granule BiogenesisLipid Transporter

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 2 of Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians

10.6084/m9.figshare.20745248figshare

Additional file 2 of Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians

10.6084/m9.figshare.20745248.v1figshare

Additional file 1 of Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians

10.6084/m9.figshare.20745245figshare

Additional file 1 of Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians

10.6084/m9.figshare.20745245.v1figshare

The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis

FAIR Checklist

Authors (31)

Funding (46 grants)

Impact

Open Access

Topics

Linked Datasets (4)

Annotations (Europe PMC)